ArticleDiagnostics (Basel, Switzerland)2021
Automatic Meniscus Segmentation Using Adversarial Learning-Based Segmentation Network with Object-Aware Map in Knee MR Images.
Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 12 citations in OpenAlex.
- Deep Learning-Based Segmentation in Musculoskeletal Imaging: A Review of Research Trends.Journal of the Korean Society of Radiology · 2025Review
- Fully and Weakly Supervised Deep Learning for Meniscal Injury Classification, and Location Based on MRI.Journal of imaging informatics in medicine · 2025Article
- Visual interpretable MRI fine grading of meniscus injury for intelligent assisted diagnosis and treatment.NPJ digital medicine · 2024Article
- Development of an automated region-of-interest-setting method based on a deep neural network for brain perfusion single photon emission computed tomography quantification methods.Asia Oceania journal of nuclear medicine & biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Meniscus segmentation from knee MR images is an essential step when analyzing the length, width, height, cross-sectional area, surface area for meniscus allograft transplantation using a 3D reconstruction model based on the patient's normal meniscus. In this paper, we propose a two-stage DCNN that combines a 2D U-Net-based meniscus localization network with a conditional generative adversarial network-based segmentation network using an object-aware map. First, the 2D U-Net segments knee MR images into six classes including bone and cartilage with whole MR images at a resolution of 512 × 512 to localize the medial and lateral meniscus. Second, adversarial learning with a generator based on the 2D U-Net and a discriminator based on the 2D DCNN using an object-aware map segments the meniscus into localized regions-of-interest with a resolution of 64 × 64. The average Dice similarity coefficient of the meniscus was 85.18% at the medial meniscus and 84.33% at the lateral meniscus; these values were 10.79%p and 1.14%p, and 7.78%p and 1.12%p higher than the segmentation method without adversarial learning and without the use of an object-aware map with the Dice similarity coefficient at the medial meniscus and lateral meniscus, respectively. The proposed automatic meniscus localization through multi-class can prevent the class imbalance problem by focusing on local regions. The proposed adversarial learning using an object-aware map can prevent under-segmentation by repeatedly judging and improving the segmentation results, and over-segmentation by considering information only from the meniscus regions. Our method can be used to identify and analyze the shape of the meniscus for allograft transplantation using a 3D reconstruction model of the patient's unruptured meniscus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.